| Aetna | Management of Meibomian Glands | 2025-11-19 |
| Aetna | Blood and Adipose Tissue Derived Products for Selected Indications | 2025-11-19 |
| Medicare WPS | Billing and Coding: Chemotherapy Agents for Non-Oncologic Conditions (55639) | 2025-11-18 |
| Medicare WPS | Billing and Coding: Wound Care (55909) | 2025-11-18 |
| Medicare WPS | Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms (59939) | 2025-11-18 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Teprotumumab-trbw (Tepezza) | 2025-11-17 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Immunizations | 2025-11-17 |
| BCBS Highmark Penn Medicare Advantage | Romosozumab-aqqg (Evenity) | 2025-11-17 |
| BCBS Highmark NY and West NY | Teprotumumab-trbw (Tepezza) | 2025-11-17 |
| BCBS Highmark NY and West NY | Immunizations | 2025-11-17 |